Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from Tonix Pharma ( (TNXP) ) is now available.
Tonix Pharmaceuticals Holding Corp. has received its first payment from the Defense Threat Reduction Agency to develop antiviral agents aimed at enhancing military personnel’s readiness against biological threats. This strategic focus on broad-spectrum antivirals highlights the company’s potential growth opportunities and underscores the importance of innovation in the defense sector. Investors should note the inherent risks and uncertainties associated with forward-looking statements regarding the company’s future performance.
For a thorough assessment of TNXP stock, go to TipRanks’ Stock Analysis page.
